WT/DS246/AB/R
7
April 2004
European Communities – Conditions for
the Granting of Tariff Preferences to Developing Countries
Report of the Appellate Body
$B!cL\
$B0F7o(B
$B>eAJ(B$B9q(B
$BHo(B$B>eAJ(B$B9q(B
$BBh;09q;22C(B
$B>e5i0Q0w%a%s%P!<(B
$B
$B7P0^(B
$B;v
$B>e5i0Q0w2qJs9p$NJ,@O(B
$B#1!%(B$B#1#9#9#4G/$N#G#A#T#T#1!%#1>r$Hr9`$H$N4X78(B
$B#2!%(B$BKcLt4XO"FCJL@)EY$Or9`$K$h$C$F@5Ev2=$5$l$k$+(B
$B>e5i0Q0w2q$N7kO@(B
$B0F7o(B
$BES>e9q$KBP$9$kFC7C4X@G(B
$B>eAJ9q(B
$B#E#C(B
$BHo>eAJ9q(B
$B%$%s%I(B
$B;22CBh;09q(B
$B%\%j%S%"!"%V%i%8%k!"%3%m%s%S%"!"%3%9%?%j%+!"%-%e!<%P!"%(%/%"%I%k!"%(%k%5%k%P%I%k!"%0%"%F%^%i!"%[%s%8%e%i%9!"%b!<%j%7%c%9!"%K%+%i%0%"!"%Q%-%9%?%s!"%Q%J%^!"%Q%i%0%"%$!"%Z%k!
e5i0Q0w2q(B>
$B>e5i0Q0w%a%s%P!<(B
George Abi-Saab
(Presiding
Member)
Luiz Olavo Baptista
Giorgio Sacerdoti
$B
$B#1#9#9#4G/$N#G#A#T#T!J#1#9#9#4G/$N4X@G5Z$SKG0W$K4X$9$k0lHL6(Dj(B; General Agreement on Tariffs and Trade 1994$B!K!"r9`!J0[$J$k$+$D0lAXM-Mx$JBT6xJB$S$KAj8_e9q$N$h$j==J,$J;22C$K$D$$$F$N7hDj!"(BDecision on Differential and More Favourable
Treatment, Reciprocity and Fuller Participation of Developing Countries$B!K(B
$B7P0^(B
$B#2#0#0#2G/!!#37n!!#5F|!!6(5DMW@A(B
$B#2#0#0#2G/#1#27n!!#6F|!!%Q%M%k@_CVMW@A(B
$B#2#0#0#3G/!!#17n#2#7F|!!%Q%M%k@_CV(B
$B#2#0#0#3G/#1#27n!!#1F|!!%Q%M%kJs9p(B
$B#2#0#0#4G/!!#47n!!#7F|!!>e5i0Q0w2qJs9p(B
$B#2#0#0#4G/!!#47n#2#0F|!!%Q%M%k!&>e5i0Q0w2qJs9p:NBr(B
$B"(%Q%M%kJs9p$K$D$$$F$O!"(B$B%Q%M%kJs9pJ,@O(B$B$r;29M$K$7$F$/$@$5$$!#(B
$B;v
$B"(;v$B%Q%M%kJs9pJ,@O(B$B$r;29M$K$7$F$/$@$5$$!#(B
$B>e5i0Q0w2qJs9p$NJ,@O!J(B()$BFb$N?t;z$OCJMnHV9f!K(B
r$NBP>]HO0O(B>$B#1!%#1#9#9#4G/$N#G#A#T#T#1!%#1>r$Hr9`$H$N4X78(B(The Relationship Between Article I:1 of the GATT 1994 and the
Enabling Clause)
$B!!#E#C$O!"-!r9`$O#1#9#9#4G/$N#G#A#T#T#1!%#1>r$N!VNc30(B(exception)$B!W$GKcLt4XO"FCJL@)EY$r@5Ev2=$9$k$?$a$N!V@Q6KE*93J[(B(affirmative defence)$B!W$G$"$k$H$7$?%Q%M%kG'Dj$O8m$j$G$"$C$?!"-"r9`$H#1#9#9#4G/$N#G#A#T#T#1!%#1>r$OF1%l%Y%k$K$"$jr9`$O#1!%#1>r$NE,MQ$rGS=|$9$k$?$a(B(the Enabling Clause exist $B!H(Bside-by-side and on an equal level$B!I(B
with Article I:1, and applies to the exclusion thereof, rather than as
an exception thereto)$B!"%$%s%I$,r9`$K4p$E$/?=N)$r9T$C$F$$$J$$$3$H$rF'$^$($F>e5i0Q0w2q$OKcLt4XO"FCJL@)EY$Hr9`$H$N@09g@-$r8!F$$9$Y$-$G$O$J$$!"$H(85)$B!#(B
$B!!>e5i0Q0w2q$Or9`$,#1#9#9#4G/$N#G#A#T#T#1!%#1>r$NE,MQ$rGS=|$;$:!"$`$7$mF1#1!%#1>r$NNc30>r9`$G$"$k$H$N%Q%M%kG'Dj$r;Y;}$7$?!#-!(BUS – Wool Shirts and Blouses$B>e5i0QJs9p$K$h$l$P!"K\7o$K$*$1$kN)>Z@UG$$NG[J,$r7h$a$k$?$a$K$O!"%$%s%I$,KcLt4XO"FCJL@)EY$Nr9`Hs@09g@-$K$D$$$F$N!V?=N)!W$r9T$o$J$1$l$P$J$i$J$$$N$+!"$"$k$$$O#E#C$,KcLt4XO"FCJL@)EY$Nr9`@09g@-$r!V93J[!W$H$7$F1gMQ$7$J$1$l$P$J$i$J$$$N$+(B(whether India must raise a $B!H(Bclaim$B!I(B and prove that the Drug
Arrangements are inconsistent with the Enabling Clause, or whether the European
Communities must raise and prove, in $B!H(Bdefence$B!I(B that
the Drug Arrangements are consistent with the Enabling Clause, in order to
justify the alleged inconsistency of the Drug Arrangements with Article I:1)$B$rH=CG$9$kI,MW$,$"$k(B(87)$B!"-"2a5n$N>e5i0Q0w2qJs9p$K$h$l$P!"$"$k>r9`$,!"K\Mh$J$i$PJL$N>r9`$N0cH?$H$J$kAu67$K$*$$$F5vMF$9$k$h$&$J>l9g$G!"$+$D$3$N#2$D$N>r9`$N$$$:$l$+$,B>J}$N>r9`$K8@5Z$7$F$$$k>l9g$K$O!"A0r9`$,8er9`$NE,MQGS=|$r<(:6$7$F$$$k>l9g$K8B$j!"?=N)9q$,A0r9`$K$D$$$FN)>Z@UG$$rIi$$(B(In cases where
one provision permits, in certain circumstances, behaviour that would otherwise
be inconsistent with an obligation in another provision, and one of the two
provisions refers to the other provision, the Appellate Body has found that the
complaining party bears the burden of establishing that a challenged measure is
inconsistent with the provision permitting particular behaviour only where one of the provisions
suggests that the obligation is not applicable to the said measure)$B!"$=$l0J30$N>l9g$K$OA0r9`$ONc30$"$k$$$O93J[$H$7$FHo?=N)9q$,N)>Z@UG$$rIi$&(B(88)$B!"-##1#9#9#4G/$N#G#A#T#T#1!%#1>r5Z$Sr9`$NJ88@$NDL>o$N0UL#$+$i!"r9`%Q%i#1$OES>e9q$K0[$J$k$+$D0lAXM-Mx$JBT6x$rM?$($k$?$a$K#1#9#9#4G/$N#G#A#T#T#1!%#1>r$N5AL3$NLH=|$rG'$a$?(B(Paragraph 1 thus excepts Members from complying with the
obligation contained in Article I:1 for the purpose of providing differential
and more favorable treatment to developing countries, provided that such
treatment is in accordance with the conditions set out in the Enabling Clause)$BNc30>r9`$@$H2r$5$l$k(B(89-90)$B!"-$r9`$O!"@h?J9q$,ES>e9q$N!V7P:Q3+H/(B(economic
development)$B!W$rB%$9$?$a$K:N$k$Y$-!V@Q6KE*$JEXNO(B(positive efforts)$B!W$H$7$F!"#W#T#O6(Dj$Nr9`$rNc30$H$_$J$7$F$b$3$NL\E*$NC#@.$,K8$2$i$l$kLu$G$O$J$$(B
(91-94)$B!"-$4D6-J]8n$b#W#T#O6(Dj$NL\E*$N$R$H$D$H$$$($k$,!"4D6-J]8n$K$D$$$F$b#1#9#9#4G/$N#G#A#T#T#2#0>r(B(g)$B$K$h$jNc30$H$7$F5,Dj$5$l$F$$$k(B(95-97)$B!"-%0J>e$rF'$^$(!"r9`$,#1#9#9#4G/$N#G#A#T#T#1!%#1>r$N!VNc30!W$G$"$k$H$$$&%Q%M%kG'Dj$r;Y;}$9$k(B(98-99)$B!"-&$5$i$K!"$"$kAr0cH?$HG'Dj$5$l$F=i$a$F$=$NAr9`$G@5Ev2=$5$l$&$k$+H]$+$,LdBj$H$J$k$N$G$"$j!"r9`$O#1#9#9#4G/$N#G#A#T#T#1!%#1>r$NE,MQ$rGS=|$9$k$o$1$G$O$J$$(B(100-103)$B!#(B
$B!!>e5i0Q0w2q$O!"0J2<$N$h$&$JM}M3$GN)>Z@UG$$K4X$9$k%Q%M%kG'Dj$r0lIt=$@5$7!"(B(i)$BK\7o$K$*$$$F$O$^$:%$%s%I$,KcLt4XO"FCJL@)EY$N0cK!@-$rr9`$NLdBj$rDs5/$9$kI,MW$,$"$k$,!"KcLt4XO"FCJL@)EY$,r9`$K$h$C$F@5Ev2=$5$l$k$3$H$K$D$$$F$O#E#C$,N)>Z@UG$$rIi$&(B(it was incumbent upon India to raise the Enabling Clause in
making its claim of inconsistency with Article I:1 of the GATT 1994, but that
the European Communities bore the burden of proving that the Drug
Arrangements satisfy the conditions of the Enabling Clause, in order to justify
those Arrangements under that Clause)$B!"(B(ii)$BK\7o$K$*$$$F%$%s%I$Or9`%Q%i#2(B(a)$B$NLdBj$rDs5/$7$F$$$k$H$$$($k(B(India sufficiently raised paragraph 2(a) of the Enabling Clause in
making its claim of inconsistency with Article I:1 before the Panel)$B!"$H=R$Y$?!#-!(BUS
– Wool Shirts and Blouses$B>e5i0QJs9p$G=R$Y$?$h$&$K!"!VNc30!W$K$D$$$F$NN)>Z@UG$$ODL>oHo?=N)9q$,Ii$$!"$7$?$,$C$FK\7o$K$*$$$F$O#E#C$,r9`$K$h$C$FKcLt4XO"FCJL@)EY$,@5Ev2=$5$l$k$3$H$K$D$$$F$NN)>Z@UG$$rIi$&$,!"(Bjura novit curia$B!J:[H==j$OK!$rCN$k!K$N86B'$K$h$l$P!"#E#C$Or9`$NFCDj$N5,Dj$K$D$$$F$NK!E*2rZ5r$r<($;$P$h$$(B(it is not the responsibility of the European Communities to
provide us with the legal interpretation to be given to a particular provision
in the Enabling Clause; instead, the burden of the European Communities is to
adduce sufficient evidence to substantiate its assertion that the Drug
Arrangements comply with the requirements of the Enabling Clause)(104-105)$B!"-"r9`$K4p$E$/93J[$r(B$BDs5/$9$k(B$BK!E*@UG$(B(legal responsibility for raising a defence)$B$K$D$$$F$O!"r9`$N#W#T#OBN@)$K$*$1$kLr3d$N=EMW@-$d$=$NFbMF!"#1#9#7#1G/$N%&%'%$%P!<7hDj$+$i8=:_$^$G$NNr;KE*7P0^$+$i?d;!$5$l$kr9`$NFCJL$J0LCV$E$1!"$^$?r9`$K4p$E$/Ar$N0cH?$H$J$k$,r9`$NMW7o$rK~$?$9>l9g$K$O#1>r$N5AL3$rLH=|$5$l$k$H$$$&;v>p$K4U$_!"r9`$K4p$E$-:N$i$l$?Ar0cH?$r(legal basis of the complaint sufficient to present the problem clearly)$B!W$r<($7$?$H$O$$$($J$$(B(106-110)$B!"-#r9`$K$O#1#9#9#4G/$N#G#A#T#T#1!%#1>r$+$i$N0oC&$,G'$a$i$l$k$?$a$N$5$^$6$^$JMW7o$,5,Dj$5$l$F$*$j!"$3$N$h$&$J5,Dj$O!V?=N)$NK!E*:,5r!W$^$?J6Ah$N!VLdBj!W$r9=@.$9$k$b$N$H$$$(!"?=N)9q$O?.5AB'$K=>$$%Q%M%k@_CVMW@A$NCf$GLdBj$H$9$kr9`$N>r9`$rFCDj$7!"(111-113)$B!"-$2CLA9q$Or9`$K4p$E$-#1>r$N5AL3$r0oC&$7ES>e9q$K!V0[$J$k$+$D0lAXM-Mx$JBT6x!W$rM?$($k$3$H$r(B$B>)Ne$5$l$F$$$k(B(encouraged)$B$H$$$&$3$H$+$i$b!"(B$BHo?=N)9q(B$B$,$I$N$h$&$JMWAG$K4p$E$-93J[$7$J$1$l$P$J$i$J$$$N$+!"(B$B?=N)9q(B$B$,E&<($7$J$1$l$P$J$i$J$$(B(a complaining party has to define the parameters within
which the responding party must make that defence)(111,
114)$B!"-%$^$?!"#E#C$,KcLt4XO"FCJL@)EY$rr9`$K$h$C$F@5Ev2=$7$h$&$H$9$k$3$H$O?=N)9q$N%$%s%I$K$b==J,M=B,$7$($?$3$H$G$"$j(B(would have been well aware)$B!"%$%s%I$O!VEv3:J6Ah$r2r7h$9$k$?$a$K@?(engage in [dispute settlement] procedures in good faith in an
effort to resolve the dispute)$B!W$?$a?=N)9q$H$7$Fr9`$NFCDj$N>r9`$K4X$9$k?=N)$rE83+$9$kI,MW(B$B$,$"$k(B(India, as the complaining party, should reasonably have
articulated its claims of inconsistency with specific provisions of the
Enabling Clause) (115-117)$B!"-&$7$+$70J>e$O!"%$%s%I$,r9`$K$D$$$FN)>Z@UG$$rIi$&$H$$$&$3$H$G$O$J$/!"r9`$K$h$C$FAZ@UG$$O#E#C$,Ii$$!"%$%s%I$N@UG$$O$"$/$^$Gr9`$N>r9`$rFCDj$9$k5AL3$K$H$I$^$k(B(115, 118)$B!"-'K\7o$K$*$$$F%$%s%I$O!"6(5DMW@A$H%Q%M%k@_CVMW@A$NCf$Gr9`%Q%i#2(B(a)$B!"#3(B(a)$B!"#3(B(c)$B$K8@5Z$7!"$^$?%Q%M%k$X$NDs=P=qLL$NCf$G!"KcLt4XO"FCJL@)EY$,r9`%Q%i#2(B(a)$B$NMW7o$rK~$?$7$F$$$J$$$H$$$&@bL@$r9T$C$F$*$j!">e=R$7$?r9`$NLdBj$rDs5/$9$k@UG$$r2L$?$7$F$$$k$H$$$($k(B(119-122)$B!#(B
$B#2!%KcLt4XO"FCJL@)EY$Or9`$K$h$C$F@5Ev2=$5$l$k$+(B(Whether the Drug Arrangements are Justified Under the Enabling
Clause)
$B!!#E#C$O!"KcLt4XO"FCJL@)EY$Or9`%Q%i#2(B(a)$B$K$h$C$F@5Ev2=$5$l$k$HeAJ$7$F$$$?!#(B
$B!!>e5i0Q0w2q$O$^$:!"K\7o>eAJ$NHO0O$K$D$$$FEv;v9q$O!"%Q%M%k$,AhE@$H$J$C$F$$$J$$LdBj!J#E#C$O0lIt$NES>e9q$r#G#S#P!J0lHLFC7C@)EY!K$NBP>]$+$iGS=|$G$-$k$+(B(whether the EC could exclude from its GSP scheme countries
claiming developing country status)$B!"#E#C$NES>e9q$NJ,N`$Or9`$NMW7o$rK~$?$7$F$$$k$+(B(whether the EC$B!G(Bs mechanisms for the gradation of developing
countries meet the requirements of the Enabling Clause)$B!K$K$D$$$F$b0E$KG'Dj$r9T$C$?$H(128)$B!"-"0J>e$rF'$^$(!">e5i0Q0w2q$O!"%$%s%I$N?=N)$,!"KcLt4XO"FCJL@)EY$,r9`%Q%i#2(B(a)$BCm#3$N!VL5:9JL$N!W$H$$$&J88@$K@09gE*$+H]$+$H$$$&LdBj$K8B$i$l$F$$$k$b$N$H2r$9(B(129)$B!"-#$^$?!"r9`%Q%i#3(B(a)$B!"#3(B(c)$B$K$D$$$F$O%Q%M%kG'Dj$,$J$5$l$F$*$i$:!"#E#C$br9`%Q%i#3(B(a)$B$r%Q%i#2(B(a)$BCm#3$NJ8L.$H$7$F1gMQ$7$F$$$k$N$_$J$N$G!">e5i0Q0w2q$OKcLt4XO"FCJL@)EY$Nr9`%Q%i#3(B(a)$B!"#3(B(c)$B@09g@-$K$D$$$F$O8!F$$7$J$$(B(130)$B!#(B
$B!!>e5i0Q0w2q$Or9`%Q%i#2(B(a)$BCm#3$N!VL5:9JL$N!W$O$9$Y$F$NES>e9q$KF10l$N4X@GFC7C$rM?$($k$3$H$r5AL3IU$1$k$b$N$G$O$J$$$H=R$Y!"$3$NE@$K4X$9$k%Q%M%kG'Dj$rGK4~$7$?!#-!r9`%Q%i#2(B(a)$B$N%U%i%s%98l5Z$S%9%Z%$%s8l$NJ88@$+$i$bL@$i$+$J$h$&$K!"r9`%Q%i#2(B(a)$B5Z$SCm#3$O!"FC7C4X@GBT6x$O#1#9#7#1G/%&%'%$%P!<7hDjA0J8$K!VDj$a$i$l$F$$$k!W#G#S#P!V$K=>$C$F!WM?$($i$l$J$1$l$P$J$i$J$$$H5,Dj$7$F$*$j(B(preferential treatment must be $B!H(Bin accordance$B!I(B with the GSP $B!H(Bas
described$B!I(B in the Preamble to the 1971 Waiver Decision)$B!"Cm#3$OFC7C4X@GBT6xIUM?9q$KK!E*5AL3$r2]$9$b$N$G$O$J$$$H$$$E#C$N(143-147)$B!"-"Cm#3!VL5:9JL$N!W$NDL>o$N0UL#$+$i$O!"$3$NJ88@$,%$%s%I$N(any differential treatment of GSP beneficiaries would be
prohibited)$B$N$+!"$"$k$$$O#E#C$Nu67$K$"$k9q$r:9JL$9$k$3$H$r6X;_$9$k$N$_$G0[$J$k>u67$K$"$k9q$r:9JL$9$k$3$H$OG'$a$F$$$k(B(differential treatment of GSP beneficiaries would not be
prohibited per se. Rather,
distinctions would be impermissible only where the basis for such distinctions
was improper)$B$N$+L@3N$G$O$J$$$,!"%$%s%I$b#E#C$bF1MM$N>u67$K$"$kES>e9q$r:9JL$9$k#G#S#P$OG'$a$i$l$J$$(B(similarly-situated GSP beneficiaries should not be treated
differently)$B$H$$$&E@$K$D$$$F$O0lCW$7$F$$$k(B(151-154)$B!"-#Cm#3!VL5:9JL$N!W$NJ8L.$H$7$F!"Cm#3$N!V0lHLE*$J(B(generalized)$B!W$H$$$&J88@$r8!F$$9$k!"%Q%M%k$O!V0lHLE*$J!W$H$$$&J88@$O!V$9$Y$F$N!WES>e9q$K!VF10l$N(B(identical)$B!W4X@GFC7C$rM?$($k$3$H$r5AL3IU$1$?$b$N$H2r(the term $B!H(Bgeneralized$B!I(B requires that the GSP schemes of
preference-granting countries remains generally applicable)$B$b$N$H2r$9$k$Y$-$G$"$k(B(155-156)$B!"-$$^$?!"Cm#3!VL5:9JL$N!W$NJL$NJ8L.$H$7$F!"r9`%Q%i#3(B(c)$B$O!"#G#S#PBN@)$K4p$E$-FC7CBT6x$rIUM?$9$k@h?J9q$KBP$7!"!V3+H/ES>e9q$N!DI,MW(B(needs of developing countries)$B!W$K!V@Q6KE*$K1~$:$k(B(respond positively)$B!W$3$H$r5AL3IU$1$F$*$j!"%Q%M%k$O(B$B$3$l$rES>e9q(B$BA4BN$N(B$B!VI,MW!W(B($B!H(Bneeds$B!I(B of developing countries collectively)$B$K1~$:$k5AL3$H2r$7$?$,!"%Q%i#3(B(c)$B$K$O!V(B$B8D!9$N(B$B!WES>e9q$NI,MW(B(needs
of $B!H(Bindividual$B!I(B developing countries)$B$K1~$:$k$3$H$rGS=|$9$kJ88@$O$J$/!"r9`%Q%i#7$d#W#T#O@_N)6(DjA0J8$Ne9q$=$l$>$l$N>u67$K1~$8$F0[$J$kFC7C$rM?$($k$3$H$bG'$a$i$l$F$$$k$H2r$9$Y$-$G$"$k(B
(157-162)$B!"-%$H$O$$$(ES>e9q$N$$$+$J$kI,MW$KBP$7$F$$$+$J$kBP1~$b$G$-$k$H$$$&$o$1$G$O$J$/!"!V3+H/>e!";q6b>e5Z$SKG0W>e$NI,MW!W$O(B$B5R4QE*$J(B$B4p=`$K4p$E$-I>2A$5$l$J$1$l$P$J$i$:(B(a $B!H(Bdevelopment, financial [or] trade need$B!I(B must be assessed
according to an objective standard)$B!"$^$?%Q%i#2$K4p$E$-M?$($i$l$kFC7CBT6x$H$3$l$K$h$C$F!V3+H/>e!";q6b>e5Z$SKG0W>e$NI,MW!W$,2r>C$9$k2DG=@-$H$N4V$K==(B$BJ,$J4X78$,$J$1$l$P$J$i$J$$(B(a sufficient nexus should exist between, on the one hand, the
preferential treatment provided under the respective measure authorized by
paragraph 2, and, on the other hand, the likelihood of alleviating the relevant
$B!H(B development, financial [or] trade need$B!I(B)$B!"0J>e$rF'$^$($k$H!"$"$k#G#S#P$K$h$C$F!V$9$Y$F$N!W(a GSP scheme may be $B!H(Bnon-discriminatory$B!I(B even if $B!H(Bidentical$B!I(B
tariff treatment is not accorded to $B!H(Ball$B!I(B GSP beneficiaries)$B$7!"$^$?FCDj$N!V3+H/>e!";q6b>e5Z$SKG0W>e$NI,MW!W$KEz$($k$?$a$K!"$=$N$h$&$J!VI,MW!W$N$"$k$9$Y$F$NES>e9q$KM?$($i$l$k4X@GFC7C$b!VL5:9JL!W$H$J$j$&$k(B(tariff preferences under GSP schemes may be $B!H(Bnon-discriminatory$B!I(B
when the relevant tariff preferences are addressed to a particular
$B!H(Bdevelopment, financial [or] trade need$B!I(B and are made available to all
beneficiaries that share that need)(163-165)$B!"-&%$%s%I$OES>e9q$Or9`$K$h$C$F#1#9#9#4G/$N#G#A#T#T#1!%#1>r$K4p$E$/8"Mx$rJ|4~$7$?$o$1$G$O$J$$$Hr9`$K4p$E$/#G#S#P$Nr$r1gMQ$9$k$3$H$O$G$-$J$$(B(166)$B!"-'#W#T#O@_N)6(Dj$NA0J8$K5,Dj$5$l$kH$i$7$F$b!"ES>e9q$N6&DL$NMx1W$N$_$J$i$:0lIt$NES>e9q$NMx1W$N$?$a$KFC7C@)EY$rMQ$$$k$3$H$O2DG=$G$"$j!"$"$kES>e9q$NFCDj$NI,MW$K1~$($k$?$a$KDI2CE*$JFC7C$rM?$($k$3$H$OG'$a$i$l$k$H2r$5$l$k(B
(168-169)$B!"-(%Q%M%k$Or9`%Q%i#2(B(d)$B$r%Q%i#2(B(a)$B$N!VNc30!W$H$_$J$7!"%Q%i#2(B(d)$B$r:,5r$K%Q%i#2(B(a)$B$O!V87L)$KF10l$NBT6x(B(formally
identical treatment)$B!W$r5a$a$F$$$k$H=R$Y$?$,!"%Q%i#2(B(d)$B$O%Q%i#2(B(a)$B$H$O0[$J$kFHN)$7$?8z2L(B(an
effect that is different and independent)$B$rM-$7$F$*$j$3$l$r:,5r$K%Q%i#2(B(a)$B$,!VF10l$N!W4X@GFC7C$r5AL3IU$1$F$$$k$H2r$9$k$3$H$O=PMh$J$$(B(171-172)$B!#(B
$B!!>e5i0Q0w2q$Or9`%Q%i#2(B(a)$BCm#3!VL5:9JL$N!W$K4X$9$k>e5-2r(a)$B$N!V3+H/ES>e9q!W$K$9$Y$F$NES>e9q$,4^$^$l$k$H$7$?%Q%M%k$N2r(175-176)$B!#(B
$B!!>e5i0Q0w2q$O!"u67$K$"$k#G#S#P(identical tariff treatment be available to all similarly-situated
GSP beneficiaries)$B$rM?$($F$$$J$$$?$a!"r9`%Q%i#2(B(a)$BCm#3$K5,Dj$5$l$k!VL5:9JL$N!WBT6x$H$O$$$($:!"$7$?$,$C$F%Q%i#2(B(a)$B$K$h$C$F@5Ev2=$5$l$J$$$H7kO@$7$?!#-!K\7oKcLt4XO"FCJL@)EY$Ne9q$K8B$i$l$F$$$k(B(181)$B!"-"e9q$OK\7oKcLt4XO"FCJL@)EY$N=$@5$K$h$C$F$N$_(182-186)$B!#(B
$B>e5i0Q0w2q$N(B$B7kO@(B
$B!!0J>e$h$j!">e5i0Q0w2q$O
(a) $Br9`$,#1#9#9#4G/$N#G#A#T#T#1!%#1>r$N!VNc30!W$G$"$k$H$7$?%Q%M%kG'Dj$r;Y;}$9$k!#(B
(b) $Br9`$,#1#9#9#4G/$N#G#A#T#T#1!%#1>r$N!VE,MQ$rGS=|$7$J$$!W$H$7$?%Q%M%kG'Dj$r;Y;}$9$k!#(B
(c) $Br9`$K$D$$$F#E#C$,N)>Z@UG$$rIi$&$H$7$?%Q%M%kG'Dj$r=$@5$7!"r9`$NLdBj$rDs5/$9$k@UG$$O%$%s%I$K$"$j!"r9`$K$h$C$FKcLt4XO"FCJL@)EY$,@5Ev2=$5$l$k$3$H$rN)>Z$9$k@UG$$O#E#C$K$"$k$HG'Dj$9$k!#$5$i$K!"%$%s%I$O$3$NE@r9`$NLdBj$rDs5/$7$?$b$N$HG'Dj$9$k!#(B
(d) $BKcLt4XO"FCJL@)EY$,#1#9#9#4G/$N#G#A#T#T#1!%#1>r$K@09gE*$G$J$$$H$7$?%Q%M%kG'Dj$K$D$$$F$OG'Dj$r9T$&I,MW$,$J$$!#(B
(e) $Br9`%Q%i#2(B(a)$BCm#3$N!VL5:9JL$N!W$H$$$&J88@$O$9$Y$F$NES>e9q$KF10l$N4X@GFC7C$rM?$($k$3$H$r5a$a$F$$$k$H$7$?%Q%M%kG'Dj$rGK4~$9$k!#(B
(f) $Br9`%Q%i#2(B(a)$B$N!V3+H/ES>e9q!W$K$O$9$Y$F$NES>e9q$,4^$^$l$k$H$7$?%Q%M%kG'Dj$rGK4~$9$k!#(B
(g) $BKcLt4XO"FCJL@)EY$Or9`%Q%i#2(B(a)$B$K$h$C$F@5Ev2=$5$l$J$$$H$7$?%Q%M%kG'Dj$r!"%Q%M%k$H0[$J$kM}M3$G;Y;}$9$k!#(B
$B!!0J>e$h$j!">e5i0Q0w2q$O!"#D#S#B!JJ6Ah2r7h5!4X!K$,#E#C$KBP$7$F#1#9#9#4G/$N#G#A#T#T#1!%#1>r$K0cH?$7r9`%Q%i#2(B(a)$B$K$h$C$F@5Ev2=$5$l$J$$$HG'Dj$5$l$?K\7oM};v2q5,B'(B2501/2001$B$r#1#9#9#4G/$N#G#A#T#T>e$N5AL3$KE,9g$5$;$k$h$&5a$a$k$3$H$r4+9p$7$?!#(B
© 2004 Yuka Fukunaga All Rights Reserved